As of 2026-03-08, the EV/EBITDA ratio of OPKO Health Inc (OPK) is -7.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPK's latest enterprise value is 885.86 mil USD. OPK's TTM EBITDA according to its financial statements is -126.17 mil USD. Dividing these 2 quantities gives us the above OPK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 10.5x | 8.6x |
| Forward P/E multiples | 8.4x - 12.2x | 10.2x |
| Fair Price | (1.35) - (1.70) | (1.53) |
| Upside | -214.8% - -244.3% | -229.4% |
| Date | EV/EBITDA |
| 2026-03-05 | -6.96 |
| 2026-03-04 | -7.14 |
| 2026-03-03 | -7.08 |
| 2026-03-02 | -7.39 |
| 2026-02-27 | -7.14 |
| 2026-02-26 | -7.14 |
| 2026-02-25 | -7.02 |
| 2026-02-24 | -6.84 |
| 2026-02-23 | -6.84 |
| 2026-02-20 | -7.14 |
| 2026-02-19 | -7.20 |
| 2026-02-18 | -7.26 |
| 2026-02-17 | -7.26 |
| 2026-02-13 | -7.33 |
| 2026-02-12 | -7.20 |
| 2026-02-11 | -7.45 |
| 2026-02-10 | -7.26 |
| 2026-02-09 | -7.26 |
| 2026-02-06 | -7.39 |
| 2026-02-05 | -7.33 |
| 2026-02-04 | -7.45 |
| 2026-02-03 | -7.51 |
| 2026-02-02 | -7.63 |
| 2026-01-30 | -7.51 |
| 2026-01-29 | -7.57 |
| 2026-01-28 | -7.63 |
| 2026-01-27 | -7.69 |
| 2026-01-26 | -7.75 |
| 2026-01-23 | -7.87 |
| 2026-01-22 | -8.12 |
| 2026-01-21 | -8.24 |
| 2026-01-20 | -7.69 |
| 2026-01-16 | -7.63 |
| 2026-01-15 | -7.63 |
| 2026-01-14 | -7.75 |
| 2026-01-13 | -7.99 |
| 2026-01-12 | -7.93 |
| 2026-01-09 | -8.12 |
| 2026-01-08 | -8.18 |
| 2026-01-07 | -8.12 |
| 2026-01-06 | -7.87 |
| 2026-01-05 | -7.63 |
| 2026-01-02 | -7.57 |
| 2025-12-31 | -7.51 |
| 2025-12-30 | -7.75 |
| 2025-12-29 | -7.69 |
| 2025-12-26 | -7.69 |
| 2025-12-24 | -7.75 |
| 2025-12-23 | -7.81 |
| 2025-12-22 | -7.93 |